From: SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
Variables | OS | RFS | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Gender(male/female) | 1.355 (0.537–3.416) | 0.520 |  |  | 1.621 (0.652–4.031) | 0.299 |  |  |
Age (> 53/≤53 years) | 1.446 (0.827–2.527) | 0.195 |  |  | 1.990 (1.970–2.011) | 0.454 |  |  |
Tumor size (> 5/≤5 cm) | 2.275 (1.296–3.994) | 0.004 |  |  | 2.603 (1.583–4.281) | 0.001 |  |  |
Differentiation (poor/well to moderate) | 1.835 (0.954–3.530) | 0.069 |  |  | 1.213 (0.721–2.040) | 0.466 |  |  |
HBsAg (positive/negative) | 1.323 (0.526–3.328) | 0.552 |  |  | 1.147 (0.524–2.509) | 0.731 |  |  |
AFP (≥200/< 200 μg/L) | 1.000 (1.081–3.281) | 0.025 | 1.395 (0.782–2.489) | 0.260 | 1.912 (1.183–3.090) | 0.008 | 1.449 (0.857–2.450) | 0.167 |
TNM stage (III + IV/I + II) | 1.516 (1.156–1.987) | 0.003 | 1.962 (1.196–3.684) | 0.031 | 1.688 (1.337–3.131) | 0.001 | 1.472 (1.131–1.916) | 0.004 |
SKA1 expression (positive/negative) | 2.497 (1.380–4.516) | 0.002 | 2.133 (1.145–3.974) | 0.017 | 1.974 (1.208–3.224) | 0.007 | 1.750 (1.064–2.878) | 0.028 |